Conjugation of polypeptides |
| OF THE INVENTION It is the object of the invention to provide polypeptide conjugates with reduced ... |
|
High molecular weight polymer-based prodrugs |
| OF THE INVENTION A. THE PRODRUGS In most aspects of the invention, the prodrug compositions of the ... |
|
Non-antigenic amine derived polymers and polymer conjugates |
| In one aspect of the invention, there are provided amine-based polymer intermediates having the ... |
|
Biodegradable high molecular weight polymeric linkers and their conjugates |
| The present invention includes compounds of the formula: (D).sub.n --M--(R.sub.1).sub.m (I) wherein ... |
|
Modified polypeptides with high activity and reduced allergenicity |
| OF THE INVENTION The modified polypeptide of the present invention is represented by the formula: A... |
|
Poly(ethylene glycol) derivatives with proximal reactive groups |
| OF THE INVENTION The terms "group," "functional group," "moiety," "active moiety," "reactive site,"... |
|
Devices for cloaking transplanted cells |
| A variety of devices can be used to contain or cloak a source of a therapeutic substance, often ... |
|
Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| In one aspect of the invention, compounds of Formula (I) are provided: ##STR6## wherein: J is ##STR7... |
|
Rectally absorbable form of L-dopa |
| What is claimed is: 1. A method of enhancing the rate of absorption of a rectally administered ... |
|
Rectally absorbable form of L-dopa |
| What is claimed is: 1. A method of enhancing the rate of absorption of a rectally administered ... |
|
|
Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
| Details |
Inventors: Cooper, Eugene R.; Jones, Stephen P.; Pouton, Colin W.; Threadgill, Michael D.;
Assignee: Sterling Winthrop Inc. (New York, NY)
Primary Examiner: Webman; Edward J.
Assistant Examiner:
Attorney, Agent or Firm: Fish & Richardson PC
A linear block copolymer comprising units of an alkylene oxide, linked to units of peptide via a linking group comprising a --CH.sub.2 CHOHCH.sub.2 N(R)-- moiety, is useful as an imaging agent, drug, prodrug or as a delivery system for imaging agents, drugs or prodrugs. |
|
DETAILED DESCRIPTION INCLUSIVE OF PREFERRED EMBODIMENTS We have discovered that linear block copolymers comprising blocks of poly(alkylene oxide) (PAGs) and peptides attached via --CH. sub. 2 CHOHCH. sub. 2 N(R)-- based linking groups are useful as imaging agents, prodrugs, drugs and drug delivery systems. Preferred copolymers are of the formula; --(PAG)N(R)CH. sub. 2 CHOHCH. sub. 2 OC. sub. 6 H. sub. 4 CO(Peptide)NH(CH. sub. 2). sub. p C. sub. 6 H. sub. 4 OCH. sub. 2 CHOHCH. sub. 2 N(R)-- Formula A or --(PAG)CH. sub. 2 CHOHCH. sub. 2 N(R)CH. sub. 2 CO(Peptide)NH(CH. sub. 2). sub. p NHCOCH. sub. 2 NR CH. sub. 2 CHOHCH. sub. 2 -- Formula B wherein R is a 1-4 carbon alkyl; and p is from 1 to 6 and the peptide is preferably Gly-Phe-Leu-Gly or Lys-Gly-Phe-Leu-Gly. The compounds can be tailored for specific uses by altering the size of the polymer or altering the peptide composition to provide differing blood pool residence time, enzymatic breakdown rates, and tissue distributions. As an imaging agent, said composition preferably has a molecular weight of at least about 5000 and a metal ion useful as a contrast enhancer, fluorophore or x-ray opaque ion associated therewith, and thus suitable for use as an agent for diagnostic imaging. An imaging metal is defined as a metal useful in x-ray imaging or a metal useful in magnetic resonance imaging, preferably a paramagnetic metal and more preferably a lanthanide metal or transition metal; or a metal useful in fluorescence imaging, preferably a lanthanide metal, most preferably Europium. This invention further provides a method of performing a diagnostic imaging procedure in a body comprising administering to the body a contrast enhancing amount of the polymer described above, and then exposing the body to a magnetic resonance measurement step to image at least a portion of the body. It is a particularly advantageous feature that the polymeric chelates of this invention provide effective imaging contrast enhancement of the blood pool within the vascular system for remarkably long periods of time
|
| Related patents |
|
|
Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
The present invention provides for compounds having the formula: ##STR1## wherein R.sub.1 is selected from the group consisting of an N-benzotriazole group, an N-2-...
|
|
|
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
OF THE INVENTION The following examples are given to illustrate the invention, but should not be considered in limitation of the invention: Example 1--Synthesis of CH....
|
|
|
Polyoxypropylene/polyoxyethylene copolmers with improved biological activity
Although the prior art preparations of polyoxypropylene/polyoxyethylene block copolymers may have been suitable for industrial uses, it has been determined that the ...
|
|
|
Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A compound of the formula ##STR10## where (a) X.sup.1 is chlorine and X.sup.2 is methyl or RO--, or (b) X.sup.2 is RO-- and X.sup.1 is NR.sup.1 R.sup.2 ...
|
|
|
Nucleic acid probes immobilized on polystyrene surfaces
We claim: 1. An article of manufacture for use in a solution phase nucleic acid sandwich hybridization assay comprising a polystyrene surface having a polypeptide ...
|
|
|
Star polymers having multiple polyisobutylene arms emanating from a calixarene core, initiators therefor, and method for the synthesis thereof
What is claimed is: 1. A composition of matter comprising: a core component selected from the group consisting of a p-methoxy cumyl group and a calix?n!arene where n=4 ...
|
|
|
High molecular weight polymer-based prodrugs
The present invention addresses the shortcomings described above. In one aspect of the invention, compositions of formula (I) are provided: ##STR3## wherein: D is a ...
|
|
|
Non-antigenic branched polymer conjugates
OF THE INVENTION 1. POLYMER SUBSTITUENTS AND FORMULA (I) DEFINED The activated branched polymers of the present invention are preferably prepared from poly(alkylene ...
|
|
|
Substantially pure histidine-linked protein polymer conjugates
In one aspect, the present invention includes substantially pure protein-polymer conjugates. The conjugates include a protein, such as an alpha interferon, covalently ...
|
|
|
Crosslinked polymer compositions and methods for their use
The present invention discloses a crosslinked polymer composition comprising a first synthetic polymer containing two or more nucleophilic groups, and a second synthetic ...
|
|
|